MD Anderson Cancer Center · 1 month ago
Postdoctoral Fellow - Leukemia
MD Anderson Cancer Center is a leading institution in cancer research, and they are seeking a Postdoctoral Fellow to join their leukemia research laboratory. The role involves conducting experimental research on leukemia, developing in vitro and in vivo models, and engaging in functional genomics studies to advance the understanding of leukemia and therapeutic approaches.
Health CareHealth DiagnosticsHospitalMedical
Responsibilities
Conducting experimental research on leukemia
Immune and inflammation-based studies in leukemia
Developing and utilizing in vitro and in vivo models for leukemia research
Performing molecular and cellular biology experiments
Engaging in functional genomics studies
Expertise in Incucyte or other cell killing assays
Expertise in flow cytometry analysis
Collaborating with both experimental and computational team members
Qualification
Required
Ph.D. in a relevant field (e.g., Molecular and Cellular biology, hematology etc)
Demonstrated experience with leukemias
Proficient in cellular molecular biology techniques
Ability to work independently as well as in a collaborative team environment
Excellent communication skills, both written and verbal
Independently able to read and interpret scientific literature, design experiments, troubleshoot experiments and present their work
Preferred
Robust background in acute myeloid leukemia
Experience in stem cell studies
Experience in preclinical studies
Experience in molecular biology
Experience in functional genomics
Experience in therapeutic targeting
Expertise in Incucyte or other cell killing assays
Expertise in flow cytometry analysis
Collaborating with both experimental and computational team members
Benefits
Medical
Dental
Paid time off
Retirement
Tuition benefits
Educational opportunities
Individual and team recognition
Company
MD Anderson Cancer Center
MD Anderson Cancer Center is a cancer treatment and research institution which gives treatment, and research of all types of cancer.
Funding
Current Stage
Late StageTotal Funding
$16.2MKey Investors
Break Through CancerGastro-Intestinal Research Foundation
2023-05-16Grant· $2.7M
2023-01-24Grant· $3.5M
2022-04-19Grant· $10M
Recent News
2026-01-19
Medical Xpress - latest medical and health news stories
2026-01-17
Company data provided by crunchbase